风湿疾病患者应用免疫抑制剂后乙型肝炎病毒再激活
被引量:2
摘要
30多年前,对乙型肝炎病毒(HBV)抗原抗体还只能进行半定量检测的时候,Wand等[1]首先报道了抗原阳性的血液肿瘤患者化疗后出现抗原滴度增加,继而肝酶增加。自那以后,更多报道证实化疗或使用免疫抑制剂患者出现HBV再激活导致肝脏炎症[2]。后来,
出处
《肝脏》
2011年第1期78-80,共3页
Chinese Hepatology
基金
四川省教育厅青年基金(08ZB093)
参考文献22
-
1Wands JR, Chura CM, Roll FJ, et al. Serial studies of hepatitis associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology, 1975,68 : 105-112.
-
2Liang R, Lau GKK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patient who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol, 1999, 17:394-398.
-
3Tur KR, Burk RD, Shaul Y, et al Hepatitis B virus DNA contains a glueocorticoid-responsive element. Proc Natl Acad Sci USA, 1986,83:1627- 1631.
-
4Lalazar G, Rund D, Shouval D. Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol, 2007, 136 :699-712.
-
5Vento S, Cainelli F, Longhi MS. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oneol, 2002, 3:333-340.
-
6Kalyoncu U, Yonem O,Calguneri M, et al. Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders. Rheumatol Int, 2009,29: 777-780.
-
7Chan TM, Fang GX, Tang CS, et al. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients. Hepatology 2002: 36: 1246-1252.
-
8Helhling B, Reichen J. Reactivation of hepatitis B following withdrawal of chloroquine [German]. Schweiz Med Woehenschr,1994, 124:759-762.
-
9Mok MY, Ng WL, Yuen MF, et al. Safety of disease modifying anti rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol, 2000, 18:363-368.
-
10Narvaez J, Rodriguez-Moreno J, Martinez-Aguila MD, et al. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. J Rheumatol, 1998,25:2037-2038.
二级参考文献15
-
1魏来.《慢性乙型肝炎防治指南》解读:病毒学、流行病学及预防[J].临床消化病杂志,2006,18(4):196-198. 被引量:5
-
2贾继东,王贵强.《慢性乙型肝炎防治指南》解读:治疗[J].临床消化病杂志,2006,18(4):200-203. 被引量:12
-
3Liang R, Lau GK, Kwong YL. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem. J Clin Oncol, 1999, 17: 394-398.
-
4Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 2006, 43: 209-220.
-
5Mok MY, Ng WL, Yuen MF, et al. Safety of disease modifying anti-rheumatic agents.in rheumatoid arthritis patients with chronic viral hepatitis. Clin Exp Rheumatol, 2000, 18: 363-368.
-
6Narvaez J, Rodriguez-Moreno J, Martinez-Aguila MD, et al. Severe hepatitis linked to B virus infection after withdrawal of low dose methotrexate therapy. J Rheumatol, 1998, 25: 2037-2038.
-
7Ito S, Nakazono K, Murasawa A, et al. Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient. Arthritis Rheum, 2001, 44: 339-342.
-
8Tsai FC, Hsieh SC, Chen DS, et al. Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents. Dig Dis Sci, 2006, 51: 1627-1632.
-
9Thong BY, Koh ET, Chng HH, et al. Outcomes of chronic hepatitis B infection in oriental patients with rheumatic diseases. Ann Acad Med Singapore, 2007, 36: 100-105.
-
10Nathan DM, Angus PW, Gibson PR. Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol, 2006, 21: 1366- 1371.
共引文献4
-
1温旭升,麦哲林,区义红.甲氨蝶呤联合拉米夫定治疗HBsAg阳性的类风湿关节炎患者的临床分析[J].国际医药卫生导报,2012,18(1):64-66. 被引量:5
-
2莫颖倩,戴冽,郑东辉,邹婵娟,马剑达,李艳华,朱浪静,张白玉.合并慢性乙型肝炎病毒感染的炎性关节病患者使用肿瘤坏死因子-α拮抗剂的肝脏安全性前瞻陛观察[J].中华风湿病学杂志,2012,16(5):317-321. 被引量:3
-
3高利霞,观美华,王飞,马永华,钟彩玲.风湿病免疫抑制剂治疗致乙肝病毒再激活的临床观察[J].中国现代医生,2014,52(3):142-145. 被引量:2
-
4金笛儿,铁宁,刘晶,赵蕾,郝东林,赵岩.炎性关节病患者肿瘤坏死因子α拮抗剂治疗后乙型肝炎病毒的活动性研究[J].中华内科杂志,2015,54(4):313-316. 被引量:2
同被引文献11
-
1陈灏珠.实用内科学[M].11版,北京:人民卫生出版社,2004:1373-1376.
-
2Raftery G, Griffiths B, Kay L, et al. Chronic viral hepatitis and TNF-alpha blockade[J]. Rheumatology ( Oxford ), 2007,46 (8) : 1381.
-
3Michel M,Duvoux C,Hezode C,et al. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset still's disease[J]. J Rheumatol, 2003,30 ( 7 ) : 1624-1625.
-
4Lee YH, Bae SC, Song GG. Hepatitis B virus reactivation in HBsAg-posi- tire patients with rheumatic diseases undergoing anti-tumor necrosis fac- tor therapy or DMARDs[J]. Int J Rheum Dis, 2013,16 (5) : 527-531.
-
5Lan JL, Chen YM, Hsieh TY, et al. Kinetics of viral loads and risk of he- patitis B virus reactivation in hepatitis B core antibody-positive rheuma- toid arthritis patients undergoing anti-tumour necrosis factor alpha thera- py[J]. Ann Rheum Dis ,2011,70(10) : 1719-1725.
-
6Giardina AR, Ferraro D, Ciccia F, et al. No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNFagents : a two-year prospective study [J]. Clin Exp Rheumatol, 2013,31 ( 1 ) : 25-30.
-
7Saag KG,Teng GG,Patkar NM ,et al. American College of Rheumatology 2008 recommendations for the use of nonbiologie and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis[J]. Arthritis Rheum, 2008,59(6) :762-784.
-
8张学武(译),李旭(译).EASL慢性乙型肝炎临床管理指南[J].国际流行病学传染病学杂志,2009,36(4):217-222. 被引量:60
-
9类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1276
-
10方霖楷,潘云峰,黄建林,金欧,曹双燕,古洁若.强直性脊柱炎伴乙型肝炎病毒携带患者使用肿瘤坏死因子拮抗剂的肝脏安全性研究[J].新医学,2011,42(3):154-157. 被引量:5
-
1过小叶,朱银芳,华忠.糖皮质激素致乙型肝炎病毒再激活1例[J].现代中西医结合杂志,2011,20(15):1895-1895.
-
2魏茂周,郑嵘,董安山,王华丽.胸腺肽α1预防乙型肝炎病毒再激活临床研究[J].中国当代医药,2012,19(7):70-71. 被引量:1
-
3江守伟,周仲松,程君,徐楠,孙秋林.糖皮质激素致乙型肝炎病毒再激活临床体会附3例分析[J].肝脏,2011,16(4):352-354.
-
4梁宏.免疫抑制治疗期间乙型肝炎病毒再激活的诊断及治疗[J].中国基层医药,2010,17(20):2791-2792. 被引量:5
-
5苏菲菲,杨守峰,赵晓云,宁洪叶,蒋贤高,朱海燕,崔小亚.拉米夫定预防结核性胸膜炎合并乙型肝炎患者激素治疗后的乙型肝炎病毒再激活[J].中华传染病杂志,2012,30(10):618-619. 被引量:2
-
6彭经宙,林泉.恩替卡韦预防肺结核患者化疗后乙型肝炎病毒再激活的疗效研究[J].现代诊断与治疗,2014,25(24):5591-5592. 被引量:2
-
7刘永振,王杰,陈香梅,鲁凤民.乙型肝炎病毒再激活研究进展[J].肝脏,2014,19(10):777-781. 被引量:6
-
8谢能文,何金秋.免疫抑制剂致乙型肝炎病毒再激活11例分析[J].实用临床医学(江西),2013,14(6):35-37.
-
9巴特尔,扎木苏荣.风湿性关节炎治验[J].蒙医药,2000,14(2):29-29.
-
10谌剑飞.风湿疾病诊断中RIA的运用与评价(文献综述)[J].放射免疫学杂志,1998,11(1):59-60. 被引量:1